Biomedical Innovation Around the World
Overview
The Duke-Margolis has engaged with multiple stakeholders to advance work on biomedical innovation and provide guidance on best practices to address regulatory challenges.
See specific projects below
Mapping Global Health Research & Development
This study aimed to identify how the US government funding decisions are determined and explore how the US government could improve its support for global health research and product development.
Funder: Global Health Technologies Coalition
Duke Lead: Duke's Center for Policy Impact in Global Health
Transferable Exclusivity Voucher
Duke-Margolis is examining whether a transferable exclusivity voucher (TEV) program for neglected tropical diseases is desirable and feasible, and if so, how to implement it. The research team conducted a stakeholder analysis, including over 20 interviews and a roundtable, and literature review.
Funder: Gates Foundation
Duke Lead: Margolis
Medical product regulatory reform in China
The Center has engaged with the National Medical Product Administration to help bring clinical trials and evidentiary standards in-line with international best practices.
Duke-Margolis Team
Jonathan Gonzalez-Smith, MPAff
Associate Research Director
Andrea Thoumi, MPP, MSc
Area Lead, Community Health and Equity
Faculty Director of Health Equity Educational Programming
Senior Team Member
Anti-Racism and Equity Committee Member
Core Faculty Member
Adjunct Assistant Professor
2020 Intern Mentor
Gavin Yamey, MD, MPH
Hymowitz Professor of the Practice of Global Health, Duke Global Health Institute
Margolis Core Faculty
2020 Intern Mentor
Morgan Romine, MPA
Chief of Staff
Senior Team Member
Beth Boyer, MPH
Policy Research Associate
